Is AIM ImmunoTech Inc halal to invest in?

As of July 2026, AIM ImmunoTech Inc AIM is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is AIM ImmunoTech Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AIM ImmunoTech Inc using these criteria to determine its compliance status.

Can Muslims buy shares of AIM ImmunoTech Inc?

Muslim investors may consider investing in AIM ImmunoTech Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is AIM ImmunoTech Inc classified as NOT HALAL?

Musaffa determines the Shariah status of AIM ImmunoTech Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for AIM ImmunoTech Inc updated?

The Shariah compliance status of AIM ImmunoTech Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like AIM ImmunoTech Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of AIM ImmunoTech Inc?

You can check the latest Shariah compliance status of AIM ImmunoTech Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

AIM Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, AIM ImmunoTech Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

AIM ImmunoTech Inc. Stock Analysis AIM

United States Health Care Nano Cap Report: Q1, 2026

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. The company is headquartered in Ocala, Florida and currently employs 19 full-time employees. The firm is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) and highly selective TLR3 agonist immuno-modulator, which is being developed for globally important cancers, viral diseases and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS). Alferon N Injection is an injectable formulation of natural alpha interferon, which is approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.

Key Statistics of AIM ImmunoTech Inc (AIM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.24$0.25

Today's Open

$0.24

Volume

343.74K

P/E Ratio (TTM)

52 Week Range

$0.21$19.74

Market Cap

6.82M

Avg. Volume

895.18K

Dividend Yield

Financial Metrics & Statements of AIM ImmunoTech Inc (AIM)

Super Investors Invested in AIM ImmunoTech Inc (AIM)

FAQ's for AIM ImmunoTech Inc (AIM)

As of July 2026, AIM ImmunoTech Inc AIM is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes AIM ImmunoTech Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in AIM ImmunoTech Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of AIM ImmunoTech Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of AIM ImmunoTech Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of AIM ImmunoTech Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.